NCT00511290

Brief Summary

In the present study inflammatory mediators will be isolated in induced sputum and exhaled breath condensate and will be correlated with particulate matter measured in these samples.Particulate matter will be assessed by partcle size distribution method and shape analysis. The aim of the study is to perform biological monitoring in environmental and occupational diseases in a non invassive fashion.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 2, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 3, 2007

Completed
Last Updated

August 3, 2007

Status Verified

August 1, 2007

First QC Date

August 2, 2007

Last Update Submit

August 2, 2007

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseInterstitial Lung DiseasesOccupational Lung Diseases

Keywords

Primary disease or condition being studied: Asthma -COPD-Interstitial Lung Diseases-Occupational Lung Diseases

Interventions

no generic namesOTHER

Eligibility Criteria

Age7 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 7-80

You may not qualify if:

  • FEV1 \< 75% predicted pO2 \< 75

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tel-Aviv Sourasky Medical Center

Tel Aviv, 64239, Israel

Location

MeSH Terms

Conditions

AsthmaPulmonary Disease, Chronic ObstructiveLung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Fireman Lizy, PhD

    Tel Aviv University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

August 2, 2007

First Posted

August 3, 2007

Last Updated

August 3, 2007

Record last verified: 2007-08

Locations

IL(1)